UNIVERSITY PARK, Pa. — To meet global demand for American ginseng, the medicinal plant traditionally collected in the forests of Appalachia and traded and used internationally, the plant now is commonly cultivated on forest farms in the U.S. Northeast. But, according to a team of researchers at Penn State and James Madison University, much of the seed for that agroforestry enterprise is coming from field-based, artificial-shade ginseng farms in Wisconsin and Ontario, Canada — and it may be influencing the genetics of naturally occurring ginseng.
To understand where forest farmers are obtaining their planting stock and better assess how human selection might affect ginseng, the team interviewed 34 ginseng growers and looked at how seeds and plants are sourced, shared and planted. The researchers found that large, commercial, artificial-shade farms in the Midwest generate extra ginseng seeds that are available for purchase online, and much of this seed is bought by smaller eastern forest growers who can’t find local or regional sources of ginseng seed. The team recently published their findings in Plants People Planet.
“This means ginseng farmed or planted in forests using commercial seed may well be shaping the genetics of ‘wild’ populations,” said study co-author Eric Burkhart, teaching professor in Penn State’s College of Agricultural Sciences.
American ginseng is considered rare or threatened in many parts of the U.S. due to overharvesting, habitat loss and poaching. Listed under Appendix II of CITES — Convention on International Trade in Endangered Species of Wild Fauna and Flora — the international trade of ginseng is strictly regulated to ensure its survival. While wild harvest is permitted in 19 states with regulations, it is banned in others.